A pancreatic cancer drug discovered in professors Paul Bingham and Zuzana Zachar’s lab in the Department of Biochemistry and Cell Biology at Stony Brook University has now entered Phase III, or multi-center testing stage.
A drug intended to attack viruses that cause the common cold is up for review.On Tuesday, advisors must decide whether to approve the experimental medication.
Picovir, made by ViroPharma Inc. and co-developed...
